Literature DB >> 32853377

Human TET2 bridges cancer and immunity.

Qian Zhang1, Jean-Laurent Casanova1,2,3,4,5.   

Abstract

Entities:  

Year:  2020        PMID： 32853377     DOI： 10.1182/blood.2020006881

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.

Authors:  Kanak Joshi; Lei Zhang; Peter Breslin S J; Ameet R Kini; Jiwang Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-10-07

2.  TET2 Inhibits PD-L1 Gene Expression in Breast Cancer Cells through Histone Deacetylation.

Authors:  Yinghui Shen; Lu Liu; Mengyuan Wang; Bo Xu; Ruitu Lyu; Yujiang Geno Shi; Li Tan
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

Review 3.  Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Authors:  Hal E Broxmeyer; Yan Liu; Reuben Kapur; Christie M Orschell; Arafat Aljoufi; James P Ropa; Thao Trinh; Sarah Burns; Maegan L Capitano
Journal:  Stem Cell Rev Rep       Date:  2020-11-03       Impact factor: 5.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.